KONZA Health joins FHIRplace as first intermediary participant

By AI, Created 8:31 PM UTC, June 02, 2026, /AGP/ – Drummond Group said June 3 that KONZA Health has joined FHIRplace as a participating intermediary, expanding testing for electronic prior authorization transactions routed between payer and provider systems. The addition is meant to help health IT developers test interoperability under real-world network conditions, not just direct connections.

Why it matters: - FHIRplace now tests prior authorization workflows with a real intermediary in the middle, closer to how payer and provider systems actually exchange data in production. - Health IT developers can use the program to see how electronic prior authorization FHIR transactions behave when routed through a trusted network instead of direct endpoints. - The expanded testing setup is meant to surface interoperability problems that direct-to-direct testing can miss.

What happened: - Drummond Group announced that KONZA Health has joined FHIRplace as a participating intermediary. - KONZA Health will route electronic prior authorization, or ePA, FHIR transactions between payer and provider endpoints in the testing program. - Drummond said the announcement came June 3, 2026. - KONZA Health becomes the first intermediary product in FHIRplace.

The details: - In production prior authorization workflows, payer and provider systems often do not communicate directly. - Intermediaries such as health information exchanges, clearinghouses and trusted exchange networks can sit between those systems and manage routing under policy and technical constraints. - FHIRplace is designed around that routing reality. - The intermediary role changes what FHIRplace participants can test because it adds governed network exchange conditions to the workflow. - FHIRplace participants can now observe how exchange behaves when routed through a trusted network, reflecting production conditions. - KONZA Health said the participation gives the company a way to demonstrate how governed network exchange performs across prior authorization use cases that matter to payers and providers. - Drummond said KONZA Health’s participation expands the range of real-world routing scenarios FHIRplace can support. - FHIRplace brings together payers, providers, EHR systems, platform developers and intermediaries that route between them. - Testing across that participant matrix is designed to reveal interoperability challenges that other testing can miss. - The program is intended to give participants confidence that their systems will be ready for live ePA interoperability.

Between the lines: - The move suggests interoperability testing is shifting from idealized point-to-point exchanges toward the messier networked setups used in actual healthcare operations. - Adding an intermediary also raises the value of the test environment for vendors that need to prove routing, governance and workflow handling, not just message compatibility. - KONZA Health’s role underscores how trusted exchange networks are becoming central to prior authorization infrastructure, even if their QHIN-specific services remain outside this testing scope.

What’s next: - FHIRplace participants can use the new intermediary setup to test more realistic prior authorization routing scenarios. - Drummond and KONZA Health are expected to continue building out the testing environment for payer, provider and intermediary interactions. - QHIN-specific services and QHIN infrastructure access remain outside the current FHIRplace testing scope.

The bottom line: - KONZA Health’s addition makes FHIRplace more representative of how electronic prior authorization is likely to work in production, where intermediaries often shape the exchange path.